Total Payments
$735,535
2024 Payments
$26,399
Companies
51
Transactions
1,744
Medicare Patients
1,340
Medicare Billing
$944,444
Payment Breakdown by Category
Other$611,924 (83.2%)
Travel$61,593 (8.4%)
Consulting$37,021 (5.0%)
Food & Beverage$24,645 (3.4%)
Education$351.81 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $601,527 | 445 | 81.8% |
| Travel and Lodging | $61,593 | 127 | 8.4% |
| Consulting Fee | $37,021 | 28 | 5.0% |
| Food and Beverage | $24,645 | 1,129 | 3.4% |
| Honoraria | $10,310 | 9 | 1.4% |
| Education | $351.81 | 4 | 0.0% |
| Grant | $87.90 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $192,981 | 251 | $0 (2024) |
| Lilly USA, LLC | $151,288 | 303 | $0 (2024) |
| ABBVIE INC. | $115,024 | 159 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $80,362 | 271 | $0 (2024) |
| Allergan, Inc. | $59,548 | 85 | $0 (2021) |
| Avanir Pharmaceuticals, Inc. | $28,550 | 64 | $0 (2021) |
| Supernus Pharmaceuticals, Inc. | $19,320 | 84 | $0 (2020) |
| IMPEL PHARMACEUTICALS INC. | $17,570 | 15 | $0 (2023) |
| Biohaven Pharmaceuticals, Inc. | $16,938 | 33 | $0 (2021) |
| Lundbeck LLC | $14,486 | 39 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $26,399 | 127 | ABBVIE INC. ($24,529) |
| 2023 | $27,910 | 78 | AbbVie Inc. ($17,512) |
| 2022 | $97,345 | 167 | ABBVIE INC. ($38,096) |
| 2021 | $120,159 | 245 | AbbVie Inc. ($34,868) |
| 2020 | $137,326 | 238 | Allergan, Inc. ($55,615) |
| 2019 | $121,548 | 328 | Lilly USA, LLC ($49,478) |
| 2018 | $155,370 | 278 | Amgen Inc. ($93,063) |
| 2017 | $49,480 | 283 | Avanir Pharmaceuticals, Inc. ($14,566) |
All Payment Transactions
1,744 individual payment records from CMS Open Payments — Page 1 of 70
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $28.72 | General |
| Category: Neurology | ||||||
| 12/18/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $21.64 | General |
| Category: Neuroscience | ||||||
| 12/13/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $2.27 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $2.20 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: Neuroscience | ||||||
| 12/10/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $10.74 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $26.81 | General |
| Category: NEUROLOGY | ||||||
| 12/05/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Musculoskeletal | ||||||
| 12/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: PAIN | ||||||
| 12/04/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: Central Nervous System | ||||||
| 11/18/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/14/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $23.50 | General |
| Category: NEUROLOGY | ||||||
| 11/14/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.01 | General |
| Category: Neuroscience | ||||||
| 11/14/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $0.49 | General |
| Category: Neuroscience | ||||||
| 11/13/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $11.07 | General |
| 11/09/2024 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $33.42 | General |
| Category: Neuroscience | ||||||
| 11/06/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: NEUROSCIENCE | ||||||
| 11/03/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $29.90 | General |
| Category: Immunology | ||||||
| 10/31/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $8.03 | General |
| Category: Neuroscience | ||||||
| 10/23/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Neurology | ||||||
| 10/17/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.92 | General |
| Category: PSYCHIATRY | ||||||
| 10/04/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $25.34 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 197 | 34,925 | $498,670 | $196,380 |
| 2022 | 10 | 345 | 45,755 | $823,704 | $283,384 |
| 2021 | 11 | 430 | 44,898 | $928,478 | $301,073 |
| 2020 | 12 | 368 | 20,031 | $568,022 | $163,606 |
Total Patients
1,340
Total Services
145,609
Medicare Billing
$944,444
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 53 | 34,600 | $415,200 | $165,390 | 39.8% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 53 | 171 | $49,590 | $18,475 | 37.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 91 | 154 | $33,880 | $12,515 | 36.9% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 71 | 44,802 | $537,624 | $213,571 | 39.7% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 71 | 229 | $66,410 | $24,709 | 37.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 100 | 177 | $38,940 | $15,090 | 38.8% |
| 64400 | Injection of anesthetic agent and/or steroid into face nerve | Office | 2022 | 11 | 116 | $68,145 | $11,604 | 17.0% |
| 64405 | Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | Office | 2022 | 14 | 122 | $42,700 | $5,862 | 13.7% |
| 64450 | Injection of anesthetic agent and/or steroid into other nerve or branch | Office | 2022 | 11 | 126 | $39,930 | $5,610 | 14.0% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2022 | 13 | 125 | $17,500 | $3,074 | 17.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 28 | 28 | $8,960 | $2,299 | 25.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 15 | $2,175 | $927.86 | 42.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 13 | 15 | $1,320 | $636.74 | 48.2% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 69 | 43,645 | $523,740 | $198,711 | 37.9% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Office | 2021 | 69 | 222 | $64,380 | $23,473 | 36.5% |
| 64505 | Injection of anesthetic agent, trigeminal nerve bundle | Office | 2021 | 13 | 117 | $56,160 | $19,098 | 34.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 83 | 159 | $34,980 | $14,852 | 42.5% |
| 64400 | Injection of anesthetic agent and/or steroid into trigeminal nerve of face | Office | 2021 | 15 | 147 | $86,435 | $13,204 | 15.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 98 | 98 | $31,360 | $11,059 | 35.3% |
| 64450 | Injection of anesthetic agent and/or steroid into other peripheral nerve or branch | Office | 2021 | 15 | 164 | $51,645 | $7,543 | 14.6% |
| 64405 | Injection of anesthetic agent and/or steroid into greater occipital nerve of upper neck and back of head | Office | 2021 | 16 | 154 | $53,900 | $7,250 | 13.5% |
| 20553 | Injections of trigger points in 3 or more muscles | Office | 2021 | 15 | 153 | $21,420 | $3,866 | 18.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 18 | 18 | $2,610 | $1,327 | 50.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 19 | 21 | $1,848 | $690.25 | 37.4% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2020 | 43 | 19,048 | $228,576 | $88,047 | 38.5% |
About Dr. Stacey Steeves, MD
Dr. Stacey Steeves, MD is a Neurology healthcare provider based in Salt Lake City, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2007. The National Provider Identifier (NPI) number assigned to this provider is 1457562233.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stacey Steeves, MD has received a total of $735,535 in payments from pharmaceutical and medical device companies, with $26,399 received in 2024. These payments were reported across 1,744 transactions from 51 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($601,527).
As a Medicare-enrolled provider, Steeves has provided services to 1,340 Medicare beneficiaries, totaling 145,609 services with total Medicare billing of $944,444. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Student in an Organized Health Care Education/Training Program, Neurology
- Location Salt Lake City, UT
- Active Since 05/24/2007
- Last Updated 08/26/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1457562233
Products in Payments
- UBRELVY (Drug) $148,121
- Aimovig (Biological) $131,894
- EMGALITY (Drug) $82,975
- AJOVY (Drug) $51,524
- REYVOW (Drug) $43,200
- NURTEC ODT (Drug) $27,027
- QULIPTA (Drug) $25,995
- AJOVY (Biological) $23,854
- TROKENDI XR (Drug) $19,305
- Trudhesa (Drug) $17,570
- NUEDEXTA (Drug) $17,343
- VYEPTI (Biological) $14,440
- QUDEXY XR Topiramate Extended Release Capsules (Drug) $11,911
- ONZETRA Xsail (Drug) $11,228
- Cambia (Drug) $9,054
- ZEPOSIA (Drug) $740.76
- MAVENCLAD (Drug) $604.55
- Mavenclad (Drug) $503.25
- AUBAGIO (Drug) $498.27
- COPAXONE (Drug) $472.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Salt Lake City
Dr. Timothy West, Md, MD
Neurology — Payments: $1.0M
Neurology $1.0M
Dr. John Foley, M.d, M.D
Neurology — Payments: $345,032
Neurology $345,032
Dr. Amir Arain, Md, MD
Neurology — Payments: $288,901
Neurology $288,901
Mark Bromberg, M.d.,Ph.d, M.D.,PH.D
Neurology — Payments: $252,027
Neurology $252,027
Lucy Dewitt, Md, MD
Neurology — Payments: $126,769
Neurology $126,769
Dr. Viktoria Kaplan, Md, MD
Neurology — Payments: $93,379
Neurology $93,379